Low-dose LC-Z300-01 twice daily in blinding for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Feb 2025: Trial registered, NCT06847178

The trials

NCT06847178: Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes

State
Not started
Phase
Phase 2 and Phase 3
People
60 planned
Started
1 Mar 2025
Primary completion
31 Oct 2025
Arms
low-dose LC-Z300-01
Results
None posted
  1. 26 Feb 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.